A case of Rasmussen encephalitis treated with rituximab

Nature Reviews Neurology

Volumn 5, Issue 8, 2009, Pages 458-462

  Thilo, Barbara ^a   Stingele, Robert ^a   Knudsen, Karina ^a   Boor, Rainer ^a   Bien, Christian G ^b   Deuschl, Günther ^a   Lang, Nicolas ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; CORTICOSTEROID; ETIRACETAM; IMMUNOGLOBULIN G; LAMOTRIGINE; MYCOPHENOLIC ACID; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; RITUXIMAB; TACROLIMUS; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE; CD19 ANTIGEN; CD20 ANTIGEN; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; ASTROCYTOSIS; BRAIN ATROPHY; BRAIN BIOPSY; BRAIN DISEASE; CASE REPORT; CLINICAL FEATURE; CORTICAL SWELLING; DISEASE COURSE; DISEASE DURATION; DISEASE EXACERBATION; DRUG DOSE REDUCTION; DRUG EFFICACY; ENCEPHALITIS; EPILEPSY; EPILEPTIC STATE; FEMALE; FOCAL EPILEPSY; HEMIPARESIS; HUMAN; IMMUNOADSORPTION; LEG; MUSCLE TWITCH; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RASMUSSEN SYNDROME; SEIZURE; TONIC CLONIC SEIZURE; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; B LYMPHOCYTE; DRUG EFFECT; IMMUNOLOGY; METABOLISM; PATHOLOGY; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD19; ANTIGENS, CD20; B-LYMPHOCYTE SUBSETS; ENCEPHALITIS; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; STATUS EPILEPTICUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70350438449     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2009.98     Document Type: Article

References (31)

1. Bien, C. G. et al. the natural history of Rasmussens encephalitis. Brain 125, 1751-1759 (2002).
2. Rasmussen, T., Olszewski, J., Lloydsmith, d. Focal seizures due to chronic localized encephalitis. Neurology 8, 435-445 (1958).
3. Bien, C. G., elger, C. e., Wiendl, H. advances in pathogenic concepts and therapeutic agents in Rasmussens encephalitis. Expert Opin. Investig. Drugs 11, 981-989 (2002).
4. Bien, C. G. et al. destruction of neurons by cytotoxic t cells: a new pathogenic mechanism in Rasmussens encephalitis. Ann. Neurol. 51, 311-318 (2002).
5. Bauer, J. et al. astrocytes are a specific immunological target in Rasmussens encephalitis. Ann. Neurol. 62, 67-80 (2007).
6. Watson, R. et al. absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis. Neurology 63, 43-50 (2004).
7. Wiendl, H. et al. GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussens encephalitis. Neurology 57, 1511-1514 (2001).
8. Mantegazza, R. et al. antibodies against GluR3 peptides are not specific for Rasmussens encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. J. Neuroimmunol. 131, 179-185 (2002).
9. Watson, R. et al. α7-acetylcholine receptor antibodies in two patients with Rasmussen encephalitis. Neurology 65, 1802-1804 (2005).
10. alvarez-Baron, E. et al. autoantibodies to Munc18, cerebral plasma cells and B-lymphocytes in Rasmussen encephalitis. Epilepsy Res. 80, 93-97 (2008).
11. Baranzini, s. e. et al. analysis of antibody gene rearrangement, usage, and specificity in chronic focal encephalitis. Neurology 58, 709-716 (2002).
12. takahashi, y. et al. autoantibodies and cellmediated autoimmunity to NMda-type GluR?2 in patients with Rasmussens encephalitis and chronic progressive epilepsia partialis continua. Epilepsia 46 (Suppl. 5), 152-158 (2005).
13. dalmau, J., Rosenfeld, M. R. Paraneoplastic syndromes of the cNs. Lancet Neurol. 7, 327-340 (2008).
14. Li, y. et al. Local-clonal expansion of infiltrating t lymphocytes in chronic encephalitis of Rasmussen. J. Immunol. 158, 1428-1437 (1997).
15. schwab, N. et al. cd8+ t-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery. Brain 132, 1236-1246 (2009).
16. Koshewnikow, a. J. a special type of cortical epilepsy [German]. Neurol. Centralbl. 14, 47-48 (1895).
17. Bien, C. G. et al. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a european consensus statement. Brain 128, 454-471 (2005).
18. thomas, J. E., Reagan, t. J., Klass, d. W. epilepsia partialis continua. a review of 32 cases. Arch. Neurol. 34, 266-275 (1977).
19. Bien, C. G. et al. diagnosis and staging of Rasmussens encephalitis by serial MRI and histopathology. Neurology 58, 250-257 (2002).
20. Honavar, M., Janota, I., Polkey, C. e. Rasmussens encephalitis in surgery for epilepsy. Dev. Med. Child Neurol. 34, 3-14 (1992).
21. Maloney, d. G. et al. Phase I clinical trial using escalating single-dose infusion of chimeric anti-cd20 monoclonal antibody (Idec-c2B8) in patients with recurrent B-cell lymphoma. Blood 84, 2457-2466 (1994).
22. Hasler, P., Zouali, M. B lymphocytes as therapeutic targets in systemic lupus erythematosus. Expert Opin. Ther. Targets 10, 803-815 (2006).
23. shlomchik, M. J., craft, J. e., Mamula, M. J. From t to B and back again: positive feedback in systemic autoimmune disease. Nat. Rev. Immunol. 1, 147-153 (2001).
24. Dalakas M. C. Invited article: inhibition of B cell functions: implications for neurology. Neurology 70, 2252-2260:2008
25. Browning, J. L. B cells move to centre stage: novel opportunities for autoimmune disease treatment. Nat. Rev. Drug Discov. 5, 564-576 (2006).
26. Martin, F., chan, a. c. B cell immunobiology in disease: evolving concepts from the clinic. Annu. Rev. Immunol. 24, 467-496 (2006).
27. edwards, J. c., cambridge, G. Prospects for B-cell-targeted therapy in autoimmune disease. Rheumatology (Oxford) 44, 151-156 (2005).
28. dalakas, M. c. B cells as therapeutic targets in autoimmune neurological disorders. Nat. Clin. Pract. Neurol. 4, 557-567 (2008).
29. Bien, C. G. et al. an open study of tacrolimus therapy in Rasmussen encephalitis. Neurology 62, 2106-2109 (2004).
30. Liossis, s. N., Sfikakis, P. P. Rituximab-induced B cell depletion in autoimmune diseases: potential effects on t cells. Clin. Immunol. 127, 280-285 (2008).
31. dubeau, F., Sherwin, a. L. Pharmacologic principles in the management of chronic focal encephalitis. In Chronic Encephalitis and Epilepsy. Rasmussens Syndrome (ed. andermann, F.) 179-192 (Butterworth- Heinemann, Boston, 1991).